Gastroenterology Calculators
Tools for hepatic assessment, prognostic scores and gastroenterological indices.
Available Calculators
Explore our collection of specialized calculators
What are Gastroenterology Calculators?
Gastroenterology calculators are specialized clinical instruments that assist gastroenterologists and hepatologists in liver function assessment, prognostic stratification of digestive diseases, and therapeutic decision guidance. They enable calculation of MELD score for liver transplant prioritization, classification of cirrhosis severity by Child-Pugh, risk assessment in acute pancreatitis, and prognosis estimation in liver diseases. Based on gastroenterology society guidelines, liver transplant protocols, and validated prognostic studies, these calculators are essential for managing liver disease patients, surgical risk stratification, and decisions regarding transplant indication.
When to Use These Tools
- MELD calculation for liver transplant queue
- Classification of cirrhosis severity by Child-Pugh
- Prognostic assessment in acute liver failure
- Risk stratification in surgery of liver disease patients
- Monitoring evolution of chronic liver disease
- Decision on indication and timing of liver transplant
Clinical Benefits
Frequently Asked Questions
How to interpret MELD score?
MELD (Model for End-Stage Liver Disease) ranges from 6-40. Values >15 indicate severe liver disease. >20 indicate high mortality risk. >30-40 indicate transplant urgency. It is used to prioritize liver allocation for transplant. Calculated with bilirubin, creatinine, and INR.
What is the difference between MELD and Child-Pugh?
Child-Pugh classifies cirrhosis into A (mild), B (moderate), or C (severe) using 5 clinical variables. MELD uses 3 laboratory variables and predicts 3-month mortality. MELD is preferred for transplant for being more objective. Child-Pugh is useful for general stratification and surgical risk.
Can MELD be used in all liver diseases?
MELD was developed for cirrhosis and end-stage liver disease. It is less accurate in acute fulminant hepatitis, hepatocellular carcinoma, or cholestatic diseases. For HCC, MELD with special exceptions is used. Always interpret MELD in the patient's complete clinical context.